Target intelligence / Profile preview

tRNA-modifying protein YgfZ (YgfZ)

Target
YgfZ
Molecular classification
Folate-binding protein, Iron-sulfur cluster assembly factor, Enzyme, Carrier protein
01

Overview

tRNA-modifying protein YgfZ is a conserved folate-binding protein that plays a pivotal role in the biogenesis and repair of iron-sulfur (Fe-S) clusters in bacteria and eukaryotes [1, 3]. In Escherichia coli, it is specifically required for the maturation of [4Fe-4S] clusters in radical S-adenosylmethionine (SAM) enzymes, such as MiaB and RimO, which catalyze essential modifications of tRNA and ribosomal proteins [8, 26]. YgfZ also functions as a regulator of chromosomal replication initiation by modulating the levels of ATP-DnaA and participates in the cellular response to oxidative stress [9, 18]. The human ortholog, IBA57, is a critical mitochondrial assembly factor, and its deficiency leads to severe neurodegenerative and metabolic conditions, including Multiple Mitochondrial Dysfunctions Syndrome 3 (MMDS3) [20, 23]. While YgfZ is considered a potential target for the development of new antimicrobial agents due to its role in bacterial fitness and stress resistance, its structural similarity to the human mitochondrial counterpart poses a significant challenge for achieving therapeutic selectivity [14, 27]. Current research focuses on understanding its precise mechanism of action and its interaction with other components of the Fe-S cluster assembly machinery [5, 30].

Other names
yzzWb2898JW2866COG0354 family proteinFolate-binding protein YgfZ
02

Mechanism of action

YgfZ facilitates the assembly and repair of [4Fe-4S] clusters by acting as a folate-dependent factor that likely removes deleterious one-carbon units or stabilizes cluster transfer to target enzymes like MiaB and RimO [1, 2, 5]. It interacts with the IscA/SufA scaffold proteins to promote the maturation of specific Fe-S proteins [7, 8].

03

Biological functions

Iron-sulfur cluster assemblytRNA modificationRegulation of chromosomal replication initiationOne-carbon metabolismOxidative stress response
04

Disease associations

InfectionMultiple mitochondrial dysfunctions syndrome 3Spastic paraplegia 74
05

Safety considerations

Potential off-target toxicity due to high homology with human mitochondrial IBA57 [10, 20]Therapeutic challenge in achieving selectivity over human mitochondrial Fe-S assembly machinery [23, 30]

Beyond the preview

Go deeper on tRNA-modifying protein YgfZ (YgfZ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tRNA-modifying protein YgfZ (YgfZ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call